DRSN4mCPred: accurately predicting sites of DNA N4-methylcytosine using deep residual shrinkage network for diagnosis and treatment of gastrointestinal cancer in the precision medicine era
IntroductionThe DNA N4-methylcytosine (4mC) site levels of those suffering from digestive system cancers were higher, 02 Sensor and the pathogenesis of digestive system cancers may also be related to the changes in DNA 4mC levels.Identifying DNA 4mC sites is a very important step in studying the analysis of biological function and cancer prediction